FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,121 | -100.0% | 309,359 | -0.6% | 0.02% | -57.4% |
| Q3 2022 | $6,977,000 | +45.4% | 311,331 | +60.8% | 0.05% | +54.3% |
| Q2 2022 | $4,798,000 | -31.5% | 193,637 | +7.2% | 0.04% | -14.6% |
| Q1 2022 | $7,003,000 | -32.9% | 180,620 | +4.0% | 0.04% | -24.1% |
| Q4 2021 | $10,434,000 | +24.0% | 173,704 | +22.4% | 0.05% | +17.4% |
| Q3 2021 | $8,413,000 | -31.7% | 141,951 | 0.0% | 0.05% | -39.5% |
| Q2 2021 | $12,320,000 | +561.3% | 141,951 | +528.1% | 0.08% | +533.3% |
| Q1 2021 | $1,863,000 | -9.3% | 22,600 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $2,055,000 | +576.0% | 22,600 | +197.4% | 0.01% | +600.0% |
| Q3 2020 | $304,000 | -62.9% | 7,600 | -68.2% | 0.00% | -71.4% |
| Q2 2020 | $820,000 | – | 23,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |